Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy <br />

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2009, Vol 1, Issue 4

Abstract

Objective: The purpose of this study was to compare the efficacy and safety of insulin glargine and detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus (DM). Methods: Thirty four children and adolescents with type 1 DM (mean age 12.7 ± 3.4 years, diabetes duration 5.4 ± 3.0 years) were included in the study. All patients had been receiving intensive insulin therapy with insulin aspart and NPH for at least 6 months before switching from NPH to insulin glargine (Group 1, n=19) or detemir (Group 2, n=15). The medical records obtained within 6 months before and after treatment with insulin glargine and detemir were retrospectively reviewed and the data were compared in each group. Results: The mean age and duration of DM were similar in two groups (p&gt;0.05). In both groups, switching from NPH to insulin glargine or detemir, resulted in a reduction in HbA1c (p0.05, for both). Patients in the detemir treated group had less increment in body mass index (BMI) SDS at the end of 6 months of therapy compared to NPH and glargine treated patients (p&gt;0.05, for both). No side effects were noted throughout the study. Conclusion: Both insulin glargine and detemir improved HbA1c at short-term and proved to be safe and well tolerated in children and adolescents with type 1 DM. DOI: 10.4008/jcrpe.v1i4.56

Authors and Affiliations

Bumin Dündar, Nihal Dündar, Erdal Eren

Keywords

Related Articles

Food Types in the Diet and the Nutrient Intake of Obese and Non-Obese Children

Background: Childhood obesity has reached epidemic proportions world-wide. Objective: To compare the types of food in the diet and the nutrient intake of obese children with those of non-obese children. Methods: A tota...

Therapeutic Approach to Obesity in Children and Adolescents

The increasing incidence of obesity and of metabolic syndrome among children and adolescents has become a problem in Turkey as in the rest of the world. Given its detrimental effects on public health and the costs of its...

A Patient with 22q11.2 Deletion Syndrome: case report

22q11 deletion is one of the most frequently encountered genetic syndromes. The phenotypic spectrum shows a wide variability. We report a boy who presented at age 11.9 years with seizures due to hypocalcemia as a result...

Vitamin D Deficiency in Children and Adolescents with Type 1 Diabetes

Ob&shy;jec&shy;ti&shy;ve: To investigate the frequency and effects of vitamin D deficiency in children with type 1 diabetes (T1D) in a region which is known to have a high rate of vitamin D deficiency among adolescents....

Physiology of Growth Hormone Secretion

Growth hormone (GH) is secreted in a pulsatile fashion from the anterior pituitary gland. The synthesis and the secretion of GH are regulated mainly by two hypothalamic neuropeptides, the growth hormone-releasing hormone...

Download PDF file
  • EP ID EP123891
  • DOI -
  • Views 112
  • Downloads 0

How To Cite

Bumin Dündar, Nihal Dündar, Erdal Eren (2009). Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy <br /> . Journal of Clinical Research in Pediatric Endocrinology, 1(4), 181-187. https://www.europub.co.uk/articles/-A-123891